11 September 2019

Rutherford Health plc

Issue of Equity

Rutherford Health plc (the "Company" or "Rutherford") has issued a notice under the Woodford Commitment, referred to in the Company's NEX Exchange Growth Market ("NEX") admission document, under which it has subscribed for 7,102,273 Rutherford ordinary shares of GBP0.001 each ("Ordinary Shares") at the maximum possible price under that agreement of GBP1.76 per Ordinary Share, in order to raise GBP12.5 million. The funds will be to provide additional working capital for the Group.

The allocation and resultant additional voting rights held by each of LF Woodford Equity Income Fund and Woodford Patient Capital Trust plc under the terms of the Woodford Commitment, will be notified in due course.

Settlement and Dealings

Application has been made for the admission to trading on NEX of the 7,102,273 Ordinary Shares on 16 September 2019 ("Admission").

Following Admission, the Company will have 179,700,533 Ordinary Shares in issue.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

The directors of Rutherford Health plc accept responsibility for this announcement.

VIEW ANNOUNCEMENT ON NEX